Recent Company News

• 09:44 PM ET May 28, 2026
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 12:14 PM ET Jun 04, 2026
  

  UK MHRA approves trivalent Aujemflu for adults 50 and older (A$92.59, 0.00)

• 01:01 AM ET Jun 03, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (51 total)

• 12:59 AM ET Jun 02, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (60 total)

• 12:49 PM ET May 28, 2026
  

  CSL downgraded to hold from buy at Jefferies (A$97.59, 0.00)

• 01:21 AM ET May 21, 2026
  

  Kissei Pharmaceutical revises package insert in Japan for TAVNEOS, issues blue letter to healthcare professionals (¥3965.0000, +95)

• 08:02 AM ET May 18, 2026
  

  Amgen issues statement on TAVNEOS in Japan; continues to engage with US FDA (post-close 15-May) ($326.31, 0.00)

• 03:21 AM ET May 15, 2026
  

  Kissei Pharmaceutical urges healthcare professionals to refrain from using TAVNEOS (avacopan) for new patients (¥4305.0000, 0)